Aster Whitefield Hospital
Day | Time |
---|---|
Sunday | Closed |
Monday | Closed |
Tuesday | Closed |
Wednesday | Closed |
Thursday | Closed |
Friday | Closed |
Saturday | Closed |
Consultation Fee
₹900
Hepatologist
4.5
Gastroscopy
Gastroenteritis Treatment
Peptic / Gastric Ulcer Treatment
Gastritis Treatment
Gall Bladder (Biliary) Stone Treatment
Steatosis
Hepatitis B Treatment
Liver Disease Treatment
ERCP
Hepatitis D Treatment
Hepatitis E Treatment
Hepatitis A Treatment
Hepatitis C Treatment
Dr. Mallikarjun Sakpal is a highly trained Hepatologist who helps people with liver, pancreas, gall bladder, and bile duct issues. He completed his MBBS from Mahadevappa Rampure Medical College in 2004, MD in Medicine from PGIMER, Chandigarh in 2008, and DM in Hepatology from the same institute in 2015.
With 19 years of overall experience and 9 years as a specialist, Dr. Mallikarjun Sakpal is skilled in Gastroscopy, Gastroenteritis Treatment, Peptic / Gastric Ulcer Treatment, Gastritis Treatment, Gall Bladder (Biliary) Stone Treatment, Steatosis, Hepatitis B Treatment, Liver Disease Treatment, ERCP, Hepatitis D Treatment, Hepatitis E Treatment, Hepatitis A Treatment, and Hepatitis C Treatment.
Dr. Mallikarjun Sakpal is known for his expertise in diagnostic and therapeutic Upper GI Endoscopy, Colonoscopy, EUS, and ERCP. He is dedicated to providing the best care for his patients before and after liver transplantation.
Patients trust Dr. Mallikarjun Sakpal because of his clear communication and compassionate approach. He stays updated with the latest medical knowledge and research to ensure his patients receive the most advanced treatments available.
Dr. Mallikarjun Sakpal collaborates well with colleagues and other medical professionals to provide comprehensive care to his patients. His work has positively impacted many lives by improving their liver health and overall well-being.
Lastly, Dr. Mallikarjun Sakpal is a skilled Hepatologist who goes above and beyond to help his patients with liver and digestive system issues. His dedication to staying updated with the latest medical advancements and his collaborative approach with colleagues make him a trusted healthcare provider in his field.
MBBS - Mahadevappa Rampure Medical College, Gulbarga, 2004
MD - Medicine - PGIMER, Chandigarh, India, 2008
DM - Hepatology - PGIMER, Chandigarh, India, 2015
68219 Karnataka Medical Council, 2004
Journal: lww
Year: 2020
Background: Guidelines for managing hepatic artery thrombosis (HAT) and stenosis (HAS) after pediatric liver transplantation (pLT) are lacking, with heterogeneous local practices. This study aims to evaluate management practices for HAT and HAS after pLT. Methods: An online and paper-based survey was sent to 36 international pLT centers. The survey included 36 questions covering center experience, screening protocols, diagnostic criteria, preventive management, post-procedural care, and follow-up. Treatment strategies were explored through hypothetical case scenarios categorized by early (≤14 d after pLT) and late onset complications (>14 d after pLT). Results: Responses from 36 centers showed that 60% applied interrupted sutures and 76% used a surgical loupe during transplantation. Additionally, 89% followed a specific anticoagulation protocol after uncomplicated pLT. All centers initiated Doppler ultrasound (DUS) within 24 hours after pLT, with 60% conducting it daily during the first week. Immediate re-transplantation was preferred for early HAT with pediatric acute liver failure (PALF) (61% vs. 11% for non-PALF, p<0.001), and surgical revascularization was more frequently chosen for non-PALF cases (51% vs. 24% for PALF, p<0.001). Endovascular therapy was selected in 35% of cases for both late HAT and HAS, with conservative management chosen in 51% for late HAT and 61% for late HAS (all p<0.001, compared to early cases). Conclusion: Internationally, there is agreement on the importance of early DUS screening in current management practices. Immediate re-transplantation was preferred for early HAT with PALF, while surgical revascularization was favored for non-PALF cases. Conservative management and endovascular therapy emerged as potential strategies for late-onset cases. This worldwide survey on real-world practice provides a basis for developing and implementing guidelines.
Dr. Mallikarjun Sakpal is a fantastic Hepatologist. He explained my condition clearly and provided effective treatment. Highly recommend him!
I had a great experience with Dr. Mallikarjun Sakpal. He is very knowledgeable and caring. I felt well taken care of under his treatment.
Dr. Mallikarjun Sakpal is an excellent Hepatologist. He listened to all my concerns patiently and offered practical solutions. I am grateful for his expertise.
I am extremely satisfied with the care I received from Dr. Mallikarjun Sakpal. He is a skilled Hepatologist who goes above and beyond for his patients.
Dr. Mallikarjun Sakpal is a compassionate and dedicated Hepatologist. He made me feel comfortable and supported throughout my treatment journey.
I highly recommend Dr. Mallikarjun Sakpal for anyone in need of a Hepatologist. He is thorough, professional, and genuinely cares about his patients' well-being.
Dr. Mallikarjun Sakpal is an exceptional Hepatologist. His expertise and kindness made a significant difference in my treatment outcome. Thank you, Dr. Sakpal!
I am grateful to have Dr. Mallikarjun Sakpal as my Hepatologist. He is not only knowledgeable but also empathetic towards his patients' needs.
Dr. Mallikarjun Sakpal is a top-notch Hepatologist. His professionalism and dedication to patient care are truly commendable. I am very impressed with his services.